BrainStorm Cell Therapeutics
BCLI
#10934
Rank
S$13.53 M
Marketcap
S$1.23
Share price
6.67%
Change (1 day)
44.90%
Change (1 year)

BrainStorm Cell Therapeutics (BCLI) - Total assets

Total assets on the balance sheet as of June 2026 : S$1 Million

According to BrainStorm Cell Therapeutics's latest financial reports the company's total assets are S$1 Million. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

BrainStorm Cell Therapeutics - Total assets on balance sheet (from 2002 to 2024)

Total assets by year

Year Total assets Change
2022-12-31S$11.32 M-71.38%
2021-12-31S$39.57 M-41.63%
2020-12-31S$67.81 M669.81%
2019-12-31S$8.8 M-42.57%
2018-12-31S$15.33 M0.4%
2017-12-31S$15.27 M-1.95%
2016-12-31S$15.58 M-35.51%
2015-12-31S$24.16 M84.49%
2014-12-31S$13.09 M118.71%
2013-12-31S$5.98 M-4.7%
2012-12-31S$6.28 M76.81%
2011-12-31S$3.55 M153.33%
2010-12-31S$1.4 M31.99%
2009-12-31S$1.06 M-15.07%
2008-12-31S$1.25 M-19.71%
2007-12-31S$1.55 M40.57%
2006-12-31S$1.1 M
2006-03-31S$1.39 M-4.06%
2005-03-31S$1.45 M5278.5%
2004-03-31S$0.02 M-66.24%
2003-03-31S$0.08 M-31.66%
2002-03-31S$0.11 M

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Biogen
BIIB
S$41.00 B 4,071,803.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
S$63.08 B 6,264,113.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Seagen
SGEN
S$4.64 B 461,100.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Cytokinetics
CYTK
S$2.45 B 244,132.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
S$0.22 B 21,815.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Acceleron Pharma
XLRN
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA